The Surface Hippy Website was conceived and designed by Patricia Walter. Patricia had her hip resurfaced in March 2006 with Dr. De Smet of Belgium. She felt there was a need for a website to help people learn about hip resurfacing. She knew first hand that it was a wonderful solution for a hip replacement and wanted to help others learn about hip resurfacing. Visit Pat’s Corner to read her informative articles about hip resurfacing including How to Choose A DoctorQuestions to Ask Your Doctor.
Surface Hippy is not financially controlled by any medical companies, doctors or hospitals. Patricia maintains the website and adds information daily. The website is a collection of information to help people learn about hip resurfacing. Surface Hippy is a patient to patient resource.
Many hip resurfacing patients have provided their personal Hip Stories so perspective patients can learn from their experiences. They explain why they chose hip resurfacing, their surgeries, the hip resurfacing device they received, what surgeon they chose, their hospital experiences and their recoveries. Many hip resurfacing patients return to the sports they love – read their stories here – Athletes Stories
If you are a first time visitor to Surface Hippy the Visitor’s Guide will help you start to learn about hip resurfacing. Learn about the difference between Hip Resurfacing and a THR.
RIDGEFIELD, Conn., November 23, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Pradaxa® (dabigatran etexilate mesylate) for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have undergone hip replacement surgery. There are an estimated 300,000 total hip replacement surgeries performed in the U.S. each year. Without preventive anticoagulant treatment, the incidence of DVT ranges from 40 to 60 percent for primary elective hip surgery patients.
“This milestone represents the fourth FDA-approved indication for PRADAXA in five years — a testament to the company’s continued leadership in the evolution of anticoagulation care for patients and clinicians,” said Sabine Luik, MD, senior vice president, Medicine & Regulatory Affairs, Boehringer Ingelheim. “PRADAXA has the longest real-world experience of any novel oral anticoagulant, and we are dedicated to ongoing research. Physicians and patients choosing PRADAXA may have added assurance knowing that it is the only novel oral anticoagulant with more than five years of use in clinical practice and a specific reversal agent.”
…”Many Americans will undergo hip replacement surgery each year. Proactive anticoagulation is vital for reducing the risk of VTE in these patients and helping to improve patient outcomes,” said Samuel Z. Goldhaber, MD, Director of Brigham and Women’s Hospital’s Thrombosis Research Group and Professor of Medicine, Harvard Medical School. “The FDA approval of this new indication for PRADAXA will help address an important public health need and provide a new therapeutic option for this large patient population.”
PRADAXA was initially approved by the FDA in 2010 to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). In 2014, the FDA approved two additional indications for PRADAXA for the treatment of DVT and PE in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated…
The decision to have a surface replacement in November, 2008, was a very good one. I have had seven years of pain-free living. Being able to bike, walk, do yard work, etc. has been a 7-year blessing. In the winter months, I walk/jog home 4.5 miles each day. I have been hesitant to jog on a regular basis due to the natural pressure of wear-and-tear on mechanical parts. I was addicted to running in my 30’s and 40’s, so the path to recovery for that addiction had already been secured through the daily pain of pre-SR. For the past two years, I have coached high school cross country which has given me the opportunity to train others in the blissful world of exercise.
During surgery, there was some kind of nerve damage done which causes my right foot and ankle to feel tight all the time. This is the situation mentioned in my first post about the recovery of the right lower leg. I don’t usually notice it during the day, and the numbness isn’t a distraction, only a minor complication of a greater relief.
If you need any advice about my experience, please contact me at firstname.lastname@example.org
I appreciate this forum to get the news and on-going progress of SR.
Hip resurfacing has become highly concentrate dto a very small number of centers and surgeons(Figure 16). Only 63 hospitals submitted resurfacing procedures. Three of those hospitals (Hospital A, B,and C) accounted for n=443 (42.7%) of all resurfacing procedures. There were three surgeons who performedmost or all of these resurfacing procedures (data
not shown). One surgeon each at Hospitals A and B performed 100% of the resurfacing procedures and another surgeon performed 90% of procedures at Hospital C. Furthermore, Figure 17 shows that the majority (82.2%) of hip resurfacing procedures were conducted on male.
Read Full Article Here
Rosemont, Ill. – November 6, 2015 – The American Joint Replacement Registry (AJRR), a multi-stakeholder, not-for-profit organization that optimizes patient outcomes through the collection of data on primary and revision hip and knee replacement procedures throughout the US, released its 2014 Annual Report on Hip and Knee Arthroplasty Data at the 2015 American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting today. This is the second annual report that AJRR has released…
The AJRR 2014 Annual Report can be found online at http://ajrr.net/publications-data/annual-reports
Jeff Wiegand had his hip resurfacing with Dr. Su in 2006. Now, 3 years post-op, Jeff Wiegand plays squash on his resurfaced hip, followed by a testimonial about resurfacing by Richard MIllman, squash coach and champion.
Web design by Patricia Walter Copyright Surface Hippy 12/11/2005
Mission Statement - Surface Hippy is a patient to patient guide to hip resurfacing.
It does not provide medical advice. It is designed to support, not to replace, the relationship between patient and clinician.
Advertising - Revenue from this site is derived from commercial advertising and individual donations.
Any advertisement is distinguished by the word "advertisement"
Privacy - Surface Hippy does not share email addresses or personal information with any group or organization.
Content - Surface Hippy is not controlled or influenced by any medical companies, doctors or hospitals.
All content is controlled by Patricia Walter - Joint Health Sites LLC